Tagged etbi

Press Release

EastGate Biotech Appoints World-Renowned Diabetes Key Opinion Leader Dr. Lalit Upadhyay for Upcoming Initiatives

 Key Opinion Leader spreading awareness of diabetes endorses the company's liquid insulin mouth rinse solution for Type 2 diabetes and pre-diabetes patients Read More
Press Release

EastGate Biotech Receives Approval to Commence a Phase 2 Trial for Liquid Insulin Mouth Rinse Solution Addressing Patient Compliance in the Type 2 Diabetes Market

 DRAP (Drug Regulatory Authority Pakistan) provided approval to commence studies of INSUGIN in Pakistan Read More
Press Release

EastGate Biotech Signs Definitive Investment and European Licensing Agreement With Nico Innovagroup S.r.l. for Liquid Insulin Mouth Rinse Solution

 Non-Dilutive Investment and Product License includes licensing fee and development costs Read More
Press Release

EastGate Biotech Provides Update on Investment From Genluiching Mining Corporation

 EastGate to receive the first non-dilutive investment tranch from the total funding up to $5 million USD as per the terms of the Definitive Agreement. Read More
Press Release

EastGate Biotech Expands Indications of Liquid Insulin Mouth Rinse Solution to Alzheimer's Disease with Joint Venture Partner Genome Pharmaceuticals

 Genome Pharma is the parent company of Netris/Origin BioPharmaceuticals the company's Joint Venture Partner Read More
Press Release

EastGate Biotech Unveils Manufacturing Plans in an MOU with Mystic Pharmaceuticals Limited for Its Liquid Insulin Mouth Rinse Solution

 Read More
Press Release

EastGate Biotech Strikes Investment and Licensing Collaboration with Nico Innovapharma for Liquid Insulin Mouth Rinse Solution for the European Market

 Investment and Product License includes licensing fee and development costs Read More
Press Release

EastGate Biotech Enters Into a Financial Agreement

 Terms of the Agreement reflects long term vision and supports company's business plan Read More
Press Release

EastGate Biotech Announces Joint Venture With Netris/Origin Biopharmaceuticals for Pakistani Market

 Drug Development and Nutraceuticals Covered in JV. Read More
Press Release

EastGate Biotech Announces Definitive Agreement with Genluiching Mining Corporation

 EastGate to receive funding in tranches up to $5 million USD. Read More
Press Release

EastGate Biotech Announces that It Has Reached a Definitive Settlement Agreement with Northbridge Financial Inc.

 The Share Reserve with Transfer Agent has been cancelled and all remaining shares have been returned to EastGate Biotech. Read More
Press Release

EastGate Biotech Enters Into a MOU with Genluiching Mining Corp. and AAH & International Associates Inc. of the Philippines

 Read More
Press Release

EastGate Biotech Announces Licensing/Distribution MOU With BuPharco for the Insulin Mouth Rinse in the Philippines for Type 2 Diabetes Patients

 Read More
Press Release

Eastgate Biotech Provides Corporate Update

 Read More
Press Release

EastGate Biotech Announces Annual Report Form 10-K Filing

 Read More
Press Release

EastGate Biotech Announces Opening of Representative Office in the Philippines

 Read More
Press Release

EastGate Biotech Announces Engagement of the Kell Group Limited for Introduction to Various Sources of Funding for Company Initiatives

 The Kell Group Limited served as an agent for related-party advances. Read More
Press Release

Eastgate Biotech Corp. Engages a New Independent Auditor

 Read More
Press Release

Eastgate Biotech Engages Agent to Identify Suitable Joint Venture Partners and Suppliers in the Philippines

 Mandate also includes collaboration with local hospital for innovative Surgical and Anti-Aging procedures Read More